Ucsd Medical Center
La Jolla, California 92161
3 studies enrolling now · 39 studies all time
What they study most
ALS, Acute Myocardial Infarction (AMI), Alzheimer's Disease, Ayerza Syndrome, CIED Related Infection, Cardiovascular Risk, Chronic Lymphocytic Leukemia, Congestive Heart Failure, Contrast Induced Nephropathy (CIN), Crohn Disease, Crohn's Disease, Follicular Lymphoma
Studies at this site
- A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH) — Recruiting now
- A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
- A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease — Recruiting now
- ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
- Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS — Stopped early
- A Study of Haploidentical Bone Marrow Transplant for Patients With Hematologic Malignancies — Stopped early
- A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease — Stopped early
- An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease — Stopped early
- Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease — Completed
- Continuous Glucose Monitoring in Infants — Status unconfirmed
- Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH) — Completed
- A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1) — Completed
- Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1) — Stopped early
- Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) — Stopped early
- Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) — Completed
- Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) — Completed
- Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) — Completed
- Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) — Completed
- Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis — Completed
- Clinical Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial Hypertension — Completed
- Inferior Vena Cava (IVC) Diameters Before & After Interscalene Block — Withdrawn before enrolling
- An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) — Completed
- Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial — Completed
- World-wide Randomized Antibiotic Envelope Infection Prevention Trial — Completed
- A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Completed
- To Assess Safety and Efficacy of Myoblast Implantation Into Myocardium Post Myocardial Infarction — Status unconfirmed
- A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis — Completed
- AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN — Completed
- A Double-Blind Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure — Completed
- A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis — Completed
- Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL) — Stopped early
- Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension — Completed
- AST-120 Used to Treat Mild Hepatic Encephalopathy — Completed
- A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH) — Stopped early
- Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05 — Stopped early
- Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects — Completed
- Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension — Completed
- Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH) — Completed
- Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease — Stopped early